Infisign Showcases Successful Interoperability for Verifiable Credential Issuance and Verification
CHENNAI, India, Nov. 18, 2023 /PRNewswire/ — Infisign, a leading Identity and Access Management (IAM) platform, proudly announces its triumphant participation in Jobs for the Future’s (JFF) PlugFest 3. The event focused on demonstrating advanced interoperability for Verifiable Credential
Global Stem Cell Collaboration and Licensing Agreements Analysis Report 2023 with Directory of 150+ Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Stem Cell Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. This report contains a comprehensive listing of 158 stem cell deals announced since 2016 including financial terms wh
Global Genitourinary Collaboration and Licensing Agreement Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Genitourinary Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access
Global Metabolic Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Metabolic Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Metabolic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the m
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Nov. 17, 2023 /CNW/ – TSX VENTURE COMPANIES OSISKO DEVELOPMENT CORP. (“ODV.WT”)BULLETIN TYPE: Warrant Expiry-DelistBULLETIN DATE: November 17, 2023TSX Venture Tier 1 Company Effective at the opening, November 29, 2023, the Share Purchase Warrants of the Compan
World Gynecology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Gynecology Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the
Global Immunology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Immunology Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the
Global Cloud in Healthcare User Survey Report 2023 – Rapid Pace of Technology Change in Healthcare Cloud Implementation
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Global Cloud User Survey, Q3, 2022” report has been added to ResearchAndMarkets.com’s offering. This global annual cloud survey’s primary goal is to determine cloud computing technology adoption among healthcare organizations,
Harbour City Shopping Mall in Hong Kong hosted a lighting ceremony to launch its “Merry Spacemas” Outdoor Christmas Decoration
HONG KONG, Nov. 18, 2023 /PRNewswire/ — Christmas is one of the most celebrated holidays in Hong Kong. Harbour City, the largest shopping mall in Hong Kong, has hosted a lighting ceremony to launch its iconic outdoor Christmas decoration display under the theme of “Merry Spacemas”
1 Day Virtual Drug Safety & Pharmacovigilance Regulatory Requirements Training Course: Learn Product Safety Regulatory Requirements for the US and EU
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Global Regulatory Requirements for Drug Safety & Pharmacovigilance” training has been added to ResearchAndMarkets.com’s offering. This training course is designed to give pharmaceutical and biologic companies operating in the US